郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

病毒感染SARS-CoV-2 B.1.1.7 infection of Syrian hamster does not cause more severe disease and is protected by naturally acquired immunity.

期刊：bioRxiv : the preprint server for biology发表年份：2021作者：Ivette A Nuñez; Christopher Z Lien; Prabhuanand Selvaraj; Charles B Stauft; Shufeng Liu; Matthew F Starost; Tony T Wang
阅读更多 →

病毒感染Immunogenicity and protective efficacy of BBV152, whole virion inactivated SARS- CoV-2 vaccine candidates in the Syrian hamster model.

期刊：iScience发表年份：2021作者：Sreelekshmy Mohandas; Pragya D Yadav; Anita Shete-Aich; Priya Abraham; Krishna Mohan Vadrevu; Gajanan Sapkal; Chandrashekhar Mote; Dimpal Nyayanit; Nivedita Gupta; Vellimedu Kannappa Srinivas; Manoj Kadam; Abhimanyu Kumar; Triparna Majumdar; Rajlaxmi
阅读更多 →

病毒感染Protective efficacy of COVAXIN® against Delta and Omicron variants in hamster model.

期刊：iScience发表年份：2022作者：Pragya D Yadav; Sreelekshmy Mohandas; Anita Shete; Gajanan Sapkal; Gururaj Deshpande; Abhimanyu Kumar; Kundan Wakchaure; Hitesh Dighe; Rajlaxmi Jain; Brunda Ganneru; Jyoti Yemul; Pranita Gawande; Krishna Mohan Vadrevu; Priya Abraham
阅读更多 →

病毒感染Ivermectin Does Not Protect against SARS-CoV-2 Infection in the Syrian Hamster Model.

期刊：Microorganisms发表年份：2022作者：Caroline S Foo; Rana Abdelnabi; Laura Vangeel; Steven De Jonghe; Dirk Jochmans; Birgit Weynand; Johan Neyts
阅读更多 →